$DREM
Dream Homes & Development Corp. Stock $drem

$drem Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000149315223018471 Filed on May 22, 2023

Income Statement

Concept	2023 Q1	2022 Q1
Revenue	$1.104M	$995.2K
YoY Change	10.98%	46.54%
Cost Of Revenue	$651.4K	$584.9K
YoY Change	11.38%	13.68%
Gross Profit	$453.0K	$410.3K
YoY Change	10.4%	149.2%
Gross Profit Margin	41.02%	41.23%
Selling, General & Admin	$295.4K	$216.0K
YoY Change	36.76%	-20.56%
% of Gross Profit	65.21%	52.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.575K	$1.690K
YoY Change	-6.8%	0.0%
% of Gross Profit	0.35%	0.41%
Operating Expenses	$297.0K	$217.7K
YoY Change	36.42%	-20.43%
Operating Profit	$156.0K	$192.6K
YoY Change	-19.01%	-276.79%
Interest Expense	$55.60K	-$27.42K
YoY Change	-302.76%	193.58%
% of Operating Profit	35.64%	-14.23%
Other Income/Expense, Net	-$55.60K	-$27.42K
YoY Change	102.75%
Pretax Income	$100.4K	$165.2K
YoY Change	-39.22%	-239.65%
Income Tax
% Of Pretax Income
Net Earnings	$100.4K	$165.2K
YoY Change	-39.22%	-239.65%
Net Earnings / Revenue	9.09%	16.6%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$4.612K
COMMON SHARES
Basic Shares Outstanding	35.82M shares	35.82M shares
Diluted Shares Outstanding	35.82M shares

Balance Sheet

Concept	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$191.1K	$127.5K
YoY Change	49.9%	-63.6%
Cash & Equivalents	$191.1K	$127.5K
Short-Term Investments
Other Short-Term Assets	$398.3K	$0.00
YoY Change		-100.0%
Inventory
Prepaid Expenses
Receivables	$191.4K	$573.9K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$946.7K	$701.4K
YoY Change	34.98%	-22.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.641K	$15.61K
YoY Change	-70.27%	-30.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$6.489M	$7.802M
YoY Change	-16.83%	1096.7%
Total Long-Term Assets	$6.494M	$7.850M
YoY Change	-17.28%	1011.34%
TOTAL ASSETS
Total Short-Term Assets	$946.7K	$701.4K
Total Long-Term Assets	$6.494M	$7.850M
Total Assets	$7.441M	$8.551M
YoY Change	-12.99%	429.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$678.8K	$395.1K
YoY Change	71.81%	65.81%
Accrued Expenses	$261.7K	$145.8K
YoY Change	79.53%	549.55%
Deferred Revenue	$41.61K
YoY Change
Short-Term Debt	$2.766M	$3.806M
YoY Change	-27.32%	1940.11%
Long-Term Debt Due	$927.7K	$913.2K
YoY Change	1.59%	145.37%
Total Short-Term Liabilities	$4.686M	$5.450M
YoY Change	-14.02%	388.66%
LONG-TERM LIABILITIES
Long-Term Debt	$2.015M	$2.451M
YoY Change	-17.79%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$2.015M	$2.451M
YoY Change	-17.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.686M	$5.450M
Total Long-Term Liabilities	$2.015M	$2.451M
Total Liabilities	$6.701M	$7.902M
YoY Change	-15.19%	608.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.537M
YoY Change
Common Stock	$35.82K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$739.3K	$650.0K
YoY Change
Total Liabilities & Shareholders Equity	$7.441M	$8.551M
YoY Change	-12.99%	429.44%

Cashflow Statement

Concept	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$100.4K	$165.2K
YoY Change	-39.22%	-239.65%
Depreciation, Depletion And Amortization	$1.575K	$1.690K
YoY Change	-6.8%	0.0%
Cash From Operating Activities	-$260.7K	$50.48K
YoY Change	-616.44%	-30.54%
INVESTING ACTIVITIES
Capital Expenditures	$307.9K	-$531.2K
YoY Change	-157.96%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$307.9K	-$531.2K
YoY Change	-42.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$234.3K	416.8K
YoY Change	-43.78%	87.75%
NET CHANGE
Cash From Operating Activities	-$260.7K	50.48K
Cash From Investing Activities	-$307.9K	-531.2K
Cash From Financing Activities	$234.3K	416.8K
Net Change In Cash	-$334.3K	-63.94K
YoY Change	422.79%
FREE CASH FLOW
Cash From Operating Activities	-$260.7K	$50.48K
Capital Expenditures	$307.9K	-$531.2K
Free Cash Flow	-$568.6K	$581.7K
YoY Change	-197.74%	700.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2022Q4	us-gaap	Other Notes Payable OtherNotesPayable		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001518336
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2023Q1	us-gaap	Increase Decrease In Due From Employee Current IncreaseDecreaseInDueFromEmployeeCurrent		usd
CY2022Q1	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale		usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt		usd
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt		usd
CY2022Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2022Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt		usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Entity File Number EntityFileNumber	000-55445
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	DREAM HOMES & DEVELOPMENT CORPORATION
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	40-0011701
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	314 South Main Street
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Forked River
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08731
CY2023Q1	dei	City Area Code CityAreaCode	609
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	693 8881
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40214493	shares
CY2023Q1	us-gaap	Cash Cash	191114	usd
CY2022Q4	us-gaap	Cash Cash	525389	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	191399	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	213008	usd
CY2023Q1	DREM	Prepaid Feesproperty Held For Development Current PrepaidFeespropertyHeldForDevelopmentCurrent	398304	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	165912	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	256558	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	946729	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	994955	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4641	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6216	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	2200	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	2200	usd
CY2023Q1	DREM	Deposits And Costs Coincident To Acquisition Of Land For Development DepositsAndCostsCoincidentToAcquisitionOfLandForDevelopment	6486968	usd
CY2022Q4	DREM	Deposits And Costs Coincident To Acquisition Of Land For Development DepositsAndCostsCoincidentToAcquisitionOfLandForDevelopment	6179085	usd
CY2023Q1	us-gaap	Assets Assets	7440538	usd
CY2022Q4	us-gaap	Assets Assets	7182456	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	678817	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	644913	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	261683	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	227308	usd
CY2023Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	10000	usd
CY2022Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	10000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	41612	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	256757	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	927660	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	908660	usd
CY2023Q1	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	1388563	usd
CY2022Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	3113563	usd
CY2023Q1	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	360142	usd
CY2022Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	492500	usd
CY2023Q1	us-gaap	Other Notes Payable OtherNotesPayable	544965	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	472820	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	254895	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4686262	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5908596	usd
CY2023Q1	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	2015016	usd
CY2022Q4	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	635016	usd
CY2023Q1	us-gaap	Liabilities Liabilities	6701278	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6543612	usd
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35824493	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35824493	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	35824	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	35824	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2240120	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2240120	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1536684	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1637100	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	739260	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	638844	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7440538	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7182456	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1104466	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	995205	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	651444	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	584866	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	453022	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	410339	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	295434	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	216022	usd
CY2023Q1	us-gaap	Depreciation Depreciation	1575	usd
CY2022Q1	us-gaap	Depreciation Depreciation	1689	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	297009	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	217711	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	156013	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	192628	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	55597	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	27422	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-55597	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-27422	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	100416	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	165206	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	100416	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	165206	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35824493	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35824493	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	484754	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	165206	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	649960	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	638844	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	638844	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	100416	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	739260	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	739260	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	100416	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	165206	usd
CY2023Q1	us-gaap	Depreciation Depreciation	1575	usd
CY2022Q1	us-gaap	Depreciation Depreciation	1689	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-21609	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-115907	usd
CY2022Q1	us-gaap	Increase Decrease In Due From Employee Current IncreaseDecreaseInDueFromEmployeeCurrent	-2705	usd
CY2023Q1	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	398304	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-90646	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	73749	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	104127	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	52415	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	34375	usd
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	25685	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-215145	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-239379	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-260701	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	50479	usd
CY2023Q1	us-gaap	Payments To Acquire Land PaymentsToAcquireLand	307883	usd
CY2022Q1	us-gaap	Payments To Acquire Land PaymentsToAcquireLand	531224	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-307883	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-531224	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	19000	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-12000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	1350000	usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	544965	usd
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	31028	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1725000	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	177702	usd
CY2023Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	196500	usd
CY2023Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	64142	usd
CY2022Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	397771	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	234309	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	416799	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-334275	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-63946	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	525389	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	191439	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	191114	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	127493	usd
CY2023Q1	DREM	Stock Issued During Period Share Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodShareRestrictedStockAwardNetOfForfeitures	2830000	shares
CY2009Q1	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	75000000	shares
CY2009Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000	shares
CY2009Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2009Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2009Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zbmGQsVSIpyb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_860_zRSt2mreXXL1">Use of Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	61246	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	59671	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4641	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6216	usd
CY2023Q1	us-gaap	Depreciation Depreciation	1575	usd
CY2022Q1	us-gaap	Depreciation Depreciation	1689	usd
CY2023Q1	DREM	Other Deposits Net OtherDepositsNet	3985545	usd
CY2022Q4	DREM	Other Deposits Net OtherDepositsNet	3677662	usd
CY2023Q1	DREM	Deposits And Costs Coincident To Acquisition Of Land For Development DepositsAndCostsCoincidentToAcquisitionOfLandForDevelopment	6486968	usd
CY2022Q4	DREM	Deposits And Costs Coincident To Acquisition Of Land For Development DepositsAndCostsCoincidentToAcquisitionOfLandForDevelopment	6179085	usd
CY2023Q1	us-gaap	Loans Payable To Bank LoansPayableToBank	3403579	usd
CY2022Q4	us-gaap	Loans Payable To Bank LoansPayableToBank	3748579	usd
CY2023Q1	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	1388563	usd
CY2022Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	3113563	usd
CY2023Q1	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	2015016	usd
CY2022Q4	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	635016	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.12	pure
CY2023Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	44745	usd
CY2022	us-gaap	Interest And Debt Expense InterestAndDebtExpense	37250	usd
CY2023Q1	us-gaap	Other Notes Payable OtherNotesPayable	544965	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	927660	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	908660	usd

Files In Submission

Name	View Source	Status
0001493152-23-018471-index-headers.html	Edgar Link	pending
0001493152-23-018471-index.html	Edgar Link	pending
0001493152-23-018471.txt	Edgar Link	pending
0001493152-23-018471-xbrl.zip	Edgar Link	pending
drem-20230331.xsd	Edgar Link	pending
ex31.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
drem-20230331_cal.xml	Edgar Link	unprocessable
drem-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
drem-20230331_def.xml	Edgar Link	unprocessable
drem-20230331_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DREM
Dream Homes & Development Corp. Stock $drem

2023 Q1 Form 10-Q Financial Statement

#000149315223018471 Filed on May 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DREM Dream Homes & Development Corp. Stock $drem

2023 Q1 Form 10-Q Financial Statement

#000149315223018471 Filed on May 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DREM
Dream Homes & Development Corp. Stock $drem